Mukherjee Sudip, Liang Lily, Veiseh Omid
Department of Bioengineering, George R. Brown School of Engineering, Rice University, Houston, TX 77005, USA.
Pharmaceutics. 2020 Feb 11;12(2):147. doi: 10.3390/pharmaceutics12020147.
Magnetic nanomaterials belong to a class of highly-functionalizable tools for cancer therapy owing to their intrinsic magnetic properties and multifunctional design that provides a multimodal theranostics platform for cancer diagnosis, monitoring, and therapy. In this review article, we have provided an overview of the various applications of magnetic nanomaterials and recent advances in the development of these nanomaterials as cancer therapeutics. Moreover, the cancer targeting, potential toxicity, and degradability of these nanomaterials has been briefly addressed. Finally, the challenges for clinical translation and the future scope of magnetic nanoparticles in cancer therapy are discussed.
Pharmaceutics. 2020-2-11
J Mater Chem B. 2015-9-14
Drug Discov Today. 2014-4
Adv Healthc Mater. 2021-1
Trends Biotechnol. 2019-3-9
Expert Opin Drug Deliv. 2014-4-25
Front Pharmacol. 2019-10-25
ACS Omega. 2023-4-10
Front Drug Deliv. 2025-7-30
Biol Direct. 2024-12-20
Cancer Cell Int. 2024-5-7
Nanoscale Adv. 2023-7-10
Exploration (Beijing). 2021-9-1
Mater Sci Eng C Mater Biol Appl. 2019-11-5
Curr Pharm Des. 2019
Phys Med Biol. 2019-3-29
Biomacromolecules. 2019-2-12